M. Krebs

Dynamics of myosin degradation in intensive care unit-acquired weakness during severe critical illness

M. Schuelke, C. Spies, T. Wollersheim, 2014, Intensive Care Medicine.

Clotting factor activity in thawed Octaplas® LG during storage at 2-6°C for 6 days from a quality assurance point of view.

K. Wernecke, C. Spies, C. von Heymann, 2012, Transfusion and apheresis science : official journal of the World Apheresis Association : official journal of the European Society for Haemapheresis.

Inflammation-Induced Acute Phase Response in Skeletal Muscle and Critical Illness Myopathy

G. Dittmar, H. Schulz, N. Hubner, 2014, PloS one.

Critically Ill Patients With Icu-Acquired Weakness Show Reduced Density of Myosin in Electron Microscope Early After Onset of Critical Illness

T. Wollersheim, S. Weber-Carstens, M. Krebs, 2015, Intensive Care Medicine Experimental.

Glycemic variability as a risk factor of intensive care unit-acquired weakness

T. Wollersheim, S. Weber-Carstens, K. Haas, 2015, Intensive Care Medicine Experimental.

[Drama in the Recovery Unit: Paediatric Emergence Delirium].

A. Hoeft, C. Spies, S. Kramer, 2018, Anasthesiologie, Intensivmedizin, Notfallmedizin, Schmerztherapie : AINS.

Long‐term recovery In critical illness myopathy is complete, contrary to polyneuropathy

T. Wollersheim, S. Weber-Carstens, M. Deja, 2014, Muscle & nerve.

Adherence to Guideline-Based Standard Operating Procedures in Pre-Hospital Emergency Patients with Chronic Obstructive Pulmonary Disease

W. Schmidbauer, C D Spies, T Kerner, 2011, The Journal of international medical research.